San Diego, California — According to state and local economic development sources Intercept Pharmaceuticals plans to invest $2,921,248.00 to build out 33,968 square feet of new space in San Diego. The company plans to occupy the new space at 9520 Towne Centre Dr. in San Diego, on or about March 1, 2021. According to the company website We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs.

To learn more about Intercept Pharmaceuticals, visit http://www.interceptpharma.com/

Company Contact:
Mark Pruzanski, Chief Executive Officer
https://www.linkedin.com/in/mark-pruzanski-876190/
844-782-4278

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved